A Placebo-controlled, Randomised, Double-blind, Crossover Study of the Efficacy of Ivabradine in the Management of Chronic Refractory Angina.
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2016
At a glance
- Drugs Ivabradine (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- 08 Jun 2016 Status changed from recruiting to completed.
- 01 Mar 2011 New trial record